Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4220 Harding Pike
S E Building Suite 200
Nashville, TN 37205Phone+1 615-385-3751Fax+1 615-269-7085
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1981- Vanderbilt University Medical CenterResidency, Internal Medicine, 1976 - 1979
Medical College of Georgia at Augusta UniversityClass of 1976
Certifications & Licensure
TN State Medical License 1978 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 34 citationsEpoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing ChemotherapyJeffrey Patton, Michael Kuzur, William Liggett, Fernando Miranda, Helen Varsos
The Oncologist. 2004-02-01 - 9 citationsGefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients.John D. Hainsworth, Mark Mainwaring, M. Thomas, Lester L. Porter, Victor G. Gian
Clinical Lung Cancer. 2003-05-01 - 33 citationsPhase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt...Hak Choy, Russell F. DeVore, Kenneth R. Hande, Lester Porter, Paul Rosenblatt
Lung Cancer. 2001-12-01
Press Mentions
‘I’m Very Confident in This Vaccine’: Dublin VA Director Reacts to VaccineDecember 29th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
